![]()
![]() CRB to licence novel fluorescent dyes with the University of Edinburgh
CRB launch highly functional new website for improved user experience
![]() Read about the launch of DISCOVERY Antibodies!
CRB to licence novel fluorescent dyes with the University of EdinburghCambridge Research Biochemicals® today signed a licence agreement with Edinburgh Innovations, the commercialisation arm of The University of Edinburgh. Under this new agreement, CRB will be permitted to label both custom made and catalogue peptides with novel dyes developed by a research team from The University of Edinburgh, School of Clinical Sciences, led by the Principal Investigator Dr Marc Vendrell. Dr Vendrell worked in collaboration with academic partners at the University of Barcelona and IRB Barcelona CRB launches much improved and highly functional new website!Cambridge Research Biochemicals recently launched its brand new, much improved, user friendly website. The site, which has been re-designed and re-launched for improved customer usability and experience and incorporates new content and design features, is based around the WordPress system. This renders the content fully amendable by CRB’s Team, which suits the custom aspect of the business in ![]() Cambridge Research Biochemicals® recently announced the release of its new DISCOVERY® Antibodies catalogue. This ties in with the three year anniversary of CRB’s expansion and relocation which took place in January 2014 and secures the company’s position as a key player in the life science industry as we enter 2017. The revival of the antibodies catalogue, first established in 1984 and sold ten years later to focus on
|
